DJS-002

N/A

Report date: 2022/10/24 13:38:34

Base Information

Drug NameDJS-002
Drug Alias NameDJS-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesDJS Abodies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDJS Abodies Ltd
Inactive CompaniesN/A
Active IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A